Dollar change -0.14
Percentage change -0.62	%

Peers: EHC AMED ENSG CHE ADUS FMS HCSG SVC SSY OPI

| Held by: VTI VB IWM VBR VXF IWO VTWO SCHA VHT FESM

Index	RUT	P/E	75.91	EPS (ttm)	0.30	Insider Own	45.71%	Shs Outstand	177.06M	Perf Week	7.99%
Market Cap	3.98B	Forward P/E	18.15	EPS next Y	1.24	Insider Trans	-34.94%	Shs Float	96.23M	Perf Month	11.64%
Enterprise Value	6.62B	PEG	2.08	EPS next Q	0.28	Inst Own	71.31%	Short Float	16.43%	Perf Quarter	-6.58%
Income	65.52M	P/S	0.33	EPS this Y	82.92%	Inst Trans	-5.59%	Short Ratio	6.29	Perf Half Y	1.63%
Sales	11.99B	P/B	2.28	EPS next Y	20.70%	ROA	0.46%	Short Interest	15.82M	Perf YTD	31.77%
Book/sh	9.84	P/C	56.73	EPS next 5Y	36.43%	ROE	1.60%	52W High	25.57 -12.24%	Perf Year	89.53%
Cash/sh	0.40	P/FCF	16.97	EPS past 3/5Y	- 60.10%	ROIC	1.50%	52W Low	11.76 90.90%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	12.46	Sales past 3/5Y	18.93% 20.01%	Gross Margin	12.88%	Volatility	3.38% 3.78%	Perf 5Y	-
Dividend TTM	-	EV/Sales	0.55	EPS Y/Y TTM	133.52%	Oper. Margin	2.85%	ATR (14)	0.79	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.34	Sales Y/Y TTM	20.60%	Profit Margin	0.55%	RSI (14)	61.84	Recom	1.15
Dividend Gr. 3/5Y	- -	Current Ratio	1.76	EPS Q/Q	12.22%	SMA20	8.07%	Beta	2.28	Target Price	28.71
Payout	-	Debt/Eq	1.56	Sales Q/Q	15.29%	SMA50	4.63%	Rel Volume	0.75	Prev Close	22.58
Employees	600	LT Debt/Eq	1.50	Earnings	Aug 01 BMO	SMA200	12.92%	Avg Volume	2.51M	Price	22.44
IPO	Jan 26, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.58% 5.30%	Trades		Volume	1,886,442	Change	-0.62%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-23-25	Initiated	TD Cowen	Buy	$37
Dec-12-24	Initiated	CJS Securities	Market Outperform
Oct-11-24	Initiated	KeyBanc Capital Markets	Sector Weight
Jun-21-24	Initiated	BTIG Research	Buy	$15
Mar-06-24	Initiated	HSBC Securities	Buy	$13
Feb-27-24	Upgrade	Deutsche Bank	Hold → Buy	$11.50
Feb-20-24	Initiated	Wells Fargo	Overweight	$15
Feb-20-24	Initiated	UBS	Buy	$15
Feb-20-24	Initiated	Morgan Stanley	Overweight	$18
Feb-20-24	Initiated	Leerink Partners	Outperform	$15
Feb-20-24	Initiated	Jefferies	Buy	$18
Feb-20-24	Initiated	Guggenheim	Buy	$15
Feb-20-24	Initiated	Goldman	Buy	$26
Feb-20-24	Initiated	Deutsche Bank	Hold	$11.50
Feb-20-24	Initiated	BofA Securities	Buy	$14

Show Previous Ratings

Aug-15-25 04:00PM	IPO Stock Of The Week: Health Care Leader BrightSpring Eyes Latest Buy Point (Investor's Business Daily)
Aug-13-25 12:02AM	BrightSpring Health Services's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Aug-12-25 11:51PM	BTSG Q2 Deep Dive: Specialty Pharmacy and Infusion Growth Shape Outlook Amid Market Caution (StockStory) +5.13%
Aug-06-25 10:19AM	Are Options Traders Betting on a Big Move in BrightSpring Health Services Stock? (Zacks)
Aug-05-25 12:00PM	BrightSpring Health Services, Inc. (BTSG) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
09:40AM	Loading…
09:40AM	Are Medical Stocks Lagging Stryker (SYK) This Year? (Zacks)
Aug-02-25 03:08AM	BrightSpring Health Services Inc (BTSG) Q2 2025 Earnings Call Highlights: Robust Revenue Growth ... (GuruFocus.com)
Aug-01-25 07:15AM	BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates (Zacks)
06:12AM	BrightSpring Health Services (NASDAQ:BTSG) Delivers Impressive Q2 (StockStory)
06:00AM	BrightSpring Health Services, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
Jul-31-25 10:01AM	5 Broker-Loved Stocks to Monitor Closely Amid Volatility (Zacks)
09:24AM	BrightSpring Health Services Inc (BTSG) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-30-25 11:02PM	BrightSpring Health Services (BTSG) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory) +6.02%
Jul-29-25 10:00AM	Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Jul-25-25 10:00AM	BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy? (Zacks)
12:03AM	Loading…
Jul-23-25 12:03AM	3 Reasons to Avoid BTSG and 1 Stock to Buy Instead (StockStory) +5.71%
Jul-17-25 09:40AM	Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year? (Zacks)
09:35AM	Down 10.4% in 4 Weeks, Here's Why You Should You Buy the Dip in BrightSpring Health Services, Inc. (BTSG) (Zacks)
08:45AM	5 Stocks Brokers Adore Even as Economic Uncertainty Lingers (Zacks)
Jul-08-25 04:05PM	BrightSpring Health Services, Inc. to Announce Second Quarter 2025 Financial Results on August 1, 2025 (GlobeNewswire)
Jul-04-25 01:48AM	BrightSpring's Onco360 Becomes National Pharmacy Partner for New Cancer, Rare Disease Therapies (Insider Monkey)
Jul-03-25 01:51PM	Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts (Zacks)
Jul-02-25 11:34AM	Centene Pulls 2025 Guidance as Marketplace Growth Falters (Zacks)
Jul-01-25 08:03AM	BrightSpring Health Leads Companies In Line For Triple-Digit Profit Growth (Investor's Business Daily) -5.60%
Jun-30-25 02:29PM	Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment (Zacks)
Jun-26-25 05:44PM	5 Revealing Analyst Questions From BrightSpring Health Services's Q1 Earnings Call (StockStory)
03:24PM	TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy (Insider Monkey)
03:00PM	BTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now? (Zacks)
Jun-25-25 10:03AM	BTSG Raises 2025 Financial Outlook: What's Backing It? (Zacks)
Jun-20-25 08:44AM	Can BrightSpring's Q1 Strength Carry Through 2025 Headwinds? (Zacks)
04:30PM	Loading…
Jun-18-25 04:30PM	BrightSpring Health Services Announces Onco360 Selected as National Pharmacy Partner for Multiple New Cancer and Rare Disease Drugs (GlobeNewswire)
Jun-17-25 08:59AM	Zacks Industry Outlook Highlights CVS Health, BrightSpring Health Services and GeneDx (Zacks)
Jun-16-25 03:57PM	Are Options Traders Betting on a Big Move in BrightSpring Stock? (Zacks)
11:09AM	3 Medical Services Stocks Capitalizing on the Healthcare AI Boom (Zacks)
07:34AM	Zacks.com featured highlights include BrightSpring Health Services, Allegiant Travel, CVR Energy, Alta Equipment Group and Cracker Barrel Old Country Store (Zacks)
Jun-13-25 11:19AM	5 Broker-Favored Stocks to Watch Amid Cooling Inflation (Zacks)
Jun-11-25 09:55AM	BrightSpring's Home Health Arm Soars: What's Powering Growth? (Zacks)
Jun-10-25 09:59PM	BrightSpring Announces Pricing of Secondary Offering of Common Stock (GlobeNewswire) -6.79%
04:16PM	BrightSpring Announces Secondary Offering of Common Stock (GlobeNewswire)
03:00PM	BrightSpring Soars to All-Time High on Quality Strength: Still a Buy? (Zacks)
Jun-06-25 12:36PM	The Real Dr. McCoy: This Health Stock With Earnings Rocketing 269% Eyes Entry (Investor's Business Daily)
Jun-05-25 07:55AM	BrightSpring's Care Ratings Climb: Is Its Lead Sustainable? (Zacks)
Jun-03-25 08:00AM	Analysts See Profits Doubling On This Energy Stock, And A Bright Spot In A Health Care Name (Investor's Business Daily)
May-30-25 11:50AM	Danaher Partners With AstraZeneca to Support Precision Medicine (Zacks)
May-29-25 09:55AM	5 Broker-Loved Stocks Amid EU Tariff Pause & Consumer Confidence Boost (Zacks)
May-26-25 08:50AM	Despite Fast-paced Momentum, BrightSpring Health Services, Inc. (BTSG) Is Still a Bargain Stock (Zacks)
May-24-25 08:00AM	Meta, Broadcom Lead Five Stocks Forging New Buy Points In Market Pullback (Investor's Business Daily)
May-23-25 09:40AM	Are Medical Stocks Lagging Amedisys (AMED) This Year? (Zacks)
May-22-25 11:33PM	BrightSpring Health Services (NASDAQ:BTSG) Q1 Earnings: Leading The Senior Health, Home Health & Hospice Pack (StockStory)
12:51PM	IBD Stock Of The Day BrightSpring Vaults To No. 1 Just 16 Months After IPO (Investor's Business Daily)
May-19-25 09:43AM	Zacks.com featured highlights include BrightSpring Health Services, Beyond, Air Canada, HF Sinclair and Emergent BioSolutions (Zacks)
May-16-25 10:52AM	5 Broker-Loved Stocks to Watch Amid Signs of Easing Trade Woes (Zacks)
09:05AM	BTSG Q1 Earnings Call: Revenue and Profit Exceed Expectations, Raises Full-Year Outlook (StockStory)
May-14-25 07:24AM	Best Momentum Stock to Buy for May 14th (Zacks)
06:21AM	New Strong Buy Stocks for May 14th (Zacks)
May-09-25 03:14PM	IPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point (Investor's Business Daily)
12:00PM	What Makes BrightSpring Health Services, Inc. (BTSG) a Strong Momentum Stock: Buy Now? (Zacks)
11:35AM	Pediatrix Medical's Q1 Earnings Beat Estimates on Declining Costs (Zacks)
May-08-25 12:31PM	Select Medical Lags Q1 Earnings Estimates, Lowers Revenue Outlook (Zacks)
12:20PM	Can BrightSpring Health Services, Inc. (BTSG) Run Higher on Rising Earnings Estimates? (Zacks)
11:39AM	TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit (Zacks)
10:00AM	Best Momentum Stocks to Buy for May 8th (Zacks)
08:50AM	BrightSpring Health Services, Inc. (BTSG) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
07:31AM	New Strong Buy Stocks for May 8th (Zacks)
May-07-25 09:40AM	Has BrightSpring Health Services, Inc. (BTSG) Outpaced Other Medical Stocks This Year? (Zacks) +5.54%
May-06-25 05:34AM	UnitedHealth, Amedisys reach new deal to sell home health and hospice locations if merger approved (Healthcare Dive)
12:32AM	1 of Wall Street's Favorite Stock with Impressive Fundamentals and 2 to Think Twice About (StockStory)
May-03-25 03:04AM	BrightSpring Health Services Inc (BTSG) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
02:03AM	Q1 2025 Brightspring Health Services Inc Earnings Call (Thomson Reuters StreetEvents)
May-02-25 03:12PM	BrightSpring Health Services, Inc. (BTSG) Q1 2025 Earnings Call Transcript (Seeking Alpha) +16.59%
07:15AM	BrightSpring Health Services, Inc. (BTSG) Q1 Earnings and Revenues Beat Estimates (Zacks)
06:00AM	BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
May-01-25 09:21AM	BrightSpring Health Services Inc (BTSG) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Apr-25-25 10:00AM	BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-17-25 05:07AM	3 Reasons to Sell BTSG and 1 Stock to Buy Instead (StockStory)
Apr-10-25 04:05PM	BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025 (GlobeNewswire)
Apr-01-25 10:23AM	Implied Volatility Surging for BrightSpring (BTSG) Stock Options (Zacks)
Mar-30-25 05:45PM	BrightSpring Health Services (BTSG): Among Top High-Risk, High-Reward Growth Stocks To Buy Now (Insider Monkey)
Mar-28-25 05:03AM	A Look Back at Senior Health, Home Health & Hospice Stocks' Q4 Earnings: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest Of The Pack (StockStory)
Mar-18-25 09:01AM	3 Healthcare Stocks Walking a Fine Line (StockStory)
Mar-12-25 05:02AM	Senior Health, Home Health & Hospice Stocks Q4 Teardown: AdaptHealth (NASDAQ:AHCO) Vs The Rest (StockStory) +5.78%
Mar-07-25 02:09AM	BrightSpring Health Services Inc (BTSG) Q4 2024 Earnings Call Highlights: Robust Revenue Growth ... (GuruFocus.com)
01:03AM	Q4 2024 Brightspring Health Services Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-06-25 07:10AM	BrightSpring Health Services, Inc. (BTSG) Q4 Earnings and Revenues Beat Estimates (Zacks) -6.31%
06:05AM	BrightSpring Health Servicess (NASDAQ:BTSG) Q4: Beats On Revenue (StockStory)
06:00AM	BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Increases Full Year 2025 Guidance (GlobeNewswire)
Mar-05-25 05:20PM	BrightSpring Health Services, Inc. Announces Promotion of Jennifer Phipps to Chief Financial Officer (GlobeNewswire)
08:05AM	BrightSpring Health Services (BTSG) Q4 Earnings: What To Expect (StockStory)
07:07AM	What To Expect From BrightSpring Health Services Inc (BTSG) Q4 2024 Earnings (GuruFocus.com)
Feb-22-25 03:59PM	BrightSpring Health Services, Inc. (BTSG): Among the Hot New Stocks to Buy Now (Insider Monkey)
Feb-14-25 03:02PM	Is Brightspring Health Services (BTSG) the Best Young Stock to Buy and Hold For 10 Years? (Insider Monkey)
01:11PM	BrightSpring Health Services, Inc. (BTSG): Among the Health Information Services Stocks Outpacing the Market in 2025 (Insider Monkey)
Feb-13-25 01:13PM	Senior Health, Home Health & Hospice Stocks Q3 Teardown: The Pennant Group (NASDAQ:PNTG) Vs The Rest (StockStory)
04:01AM	Senior Health, Home Health & Hospice Stocks Q3 Earnings Review: Option Care Health (NASDAQ:OPCH) Shines (StockStory)
Feb-11-25 08:30AM	Are Options Traders Betting on a Big Move in BrightSpring Health Services, Inc. (BTSG) Stock? (Zacks)
04:03AM	Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest (StockStory)
Feb-06-25 04:05PM	BrightSpring Health Services, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 (GlobeNewswire)
Feb-02-25 04:31PM	Why BrightSpring Health Services, Inc. (BTSG) Is Among the Best Booming Stocks to Invest in Now? (Insider Monkey)
Jan-22-25 05:36AM	BrightSpring Health Services, Inc. (BTSG) Soars 12.6%: Is Further Upside Left in the Stock? (Zacks)
02:00AM	BrightSpring Health Services Inc (BTSG) Q4 2024 Earnings Call Highlights: Strategic Divestiture ... (GuruFocus.com)

BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McMaude Michael A	Former Officer	Aug 14 '25	Proposed Sale	22.40	16,168	362,241		Aug 14 05:53 PM
KKR Group Partnership L.P.	10% Owner	Jun 24 '25	Sale	21.15	2,100,000	44,418,990	77,096,337	Jun 26 04:31 PM
KKR Phoenix Aggregator L.P.	10% Owner	Jun 24 '25	Sale	21.15	2,100,000	44,418,990	77,096,337	Jun 26 04:30 PM
KKR Group Partnership L.P.	10% Owner	Jun 12 '25	Sale	21.15	13,288,101	281,068,584	79,671,883	Jun 16 08:08 PM
KKR Phoenix Aggregator L.P.	10% Owner	Jun 12 '25	Sale	21.15	13,288,101	281,068,584	79,671,883	Jun 16 08:08 PM
Phipps Jennifer A	Chief Accounting Officer	Jun 12 '25	Option Exercise	6.37	15,616	99,474	245,646	Jun 13 04:04 PM
Phipps Jennifer A	Chief Accounting Officer	Jun 12 '25	Sale	21.75	15,616	339,648	230,030	Jun 13 04:04 PM
Nalley Lisa A	See Remarks	Jun 12 '25	Option Exercise	6.37	14,415	91,824	145,565	Jun 13 04:03 PM
Nalley Lisa A	See Remarks	Jun 12 '25	Sale	21.75	14,415	313,526	131,150	Jun 13 04:03 PM
ROUSSEAU JON B	See Remarks	Jun 12 '25	Option Exercise	6.37	531,840	3,387,821	1,715,973	Jun 13 04:03 PM
ROUSSEAU JON B	See Remarks	Jun 12 '25	Sale	21.75	531,840	11,567,520	1,184,133	Jun 13 04:03 PM
McMaude Michael A	See Remarks	Jun 12 '25	Sale	21.75	119,298	2,594,732	207,590	Jun 13 04:02 PM
Barnes Robert Allen	President, Community Living	Jun 12 '25	Option Exercise	6.37	27,606	175,850	69,999	Jun 13 04:02 PM
Barnes Robert Allen	President, Community Living	Jun 12 '25	Sale	21.75	30,730	668,378	39,269	Jun 13 04:02 PM
Walgreens Boots Alliance, Inc.	Former 10% owner	Feb 18 '25	Sale	21.16	12,000,000	253,920,000	11,239,996	Feb 20 04:30 PM
Walgreen Co.	10% Owner	Feb 18 '25	Proposed Sale	22.15	12,000,000	265,800,000		Feb 18 09:07 PM
Walgreens Boots Alliance, Inc.	10% Owner	Sep 11 '24	Sale	11.13	11,619,998	129,330,578	23,239,996	Sep 13 07:04 PM
KKR Group Partnership L.P.	10% Owner	Sep 11 '24	Buy	11.13	11,619,998	129,330,578	92,959,984	Sep 13 04:44 PM
KKR Phoenix Aggregator L.P.	10% Owner	Sep 11 '24	Buy	11.13	11,619,998	129,330,578	92,959,984	Sep 13 04:36 PM

Open in Screener

COR

Cencora Inc

Aug 15 • 04:00PM ET

292.82

Dollar change -2.05
Percentage change -0.70	%

Healthcare • Medical Distribution • USA • NYSE

Peers: CAH MCK HSIC OMI PDCO DXCM BIO HCA LH

| Held by: VTI VOO VO IVV SPY VTV IWP VOE XLV USMV

Index	S&P 500	P/E	30.12	EPS (ttm)	9.72	Insider Own	5.32%	Shs Outstand	193.86M	Perf Week	2.70%
Market Cap	56.77B	Forward P/E	16.79	EPS next Y	17.44	Insider Trans	-1.32%	Shs Float	183.56M	Perf Month	-0.53%
Enterprise Value	62.97B	PEG	2.58	EPS next Q	3.79	Inst Own	93.68%	Short Float	3.53%	Perf Quarter	2.40%
Income	1.90B	P/S	0.18	EPS this Y	15.79%	Inst Trans	3.08%	Short Ratio	5.00	Perf Half Y	19.75%
Sales	316.65B	P/B	28.67	EPS next Y	9.43%	ROA	2.70%	Short Interest	6.48M	Perf YTD	30.33%
Book/sh	10.21	P/C	24.95	EPS next 5Y	11.66%	ROE	130.60%	52W High	309.35 -5.34%	Perf Year	23.91%
Cash/sh	11.74	P/FCF	49.73	EPS past 3/5Y	0.66% 13.29%	ROIC	18.93%	52W Low	218.65 33.92%	Perf 3Y	101.14%
Dividend Est.	2.22 (0.76%)	EV/EBITDA	13.87	Sales past 3/5Y	11.16% 10.36%	Gross Margin	3.06%	Volatility	2.65% 2.26%	Perf 5Y	184.18%
Dividend TTM	2.16 (0.74%)	EV/Sales	0.20	EPS Y/Y TTM	5.31%	Oper. Margin	1.09%	ATR (14)	6.89	Perf 10Y	180.59%
Dividend Ex-Date	Aug 15, 2025	Quick Ratio	0.53	Sales Y/Y TTM	11.56%	Profit Margin	0.60%	RSI (14)	52.34	Recom	1.78
Dividend Gr. 3/5Y	5.04% 4.98%	Current Ratio	0.90	EPS Q/Q	45.69%	SMA20	1.08%	Beta	0.62	Target Price	338.38
Payout	27.07%	Debt/Eq	4.16	Sales Q/Q	8.65%	SMA50	0.14%	Rel Volume	0.84	Prev Close	294.87
Employees	46000	LT Debt/Eq	4.06	Earnings	Aug 06 BMO	SMA200	9.88%	Avg Volume	1.30M	Price	292.82
IPO	Apr 04, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.96% 0.71%	Trades		Volume	1,081,838	Change	-0.70%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$337
Dec-04-24	Resumed	Mizuho	Outperform	$280
Sep-18-24	Downgrade	BofA Securities	Buy → Neutral	$275 → $245
Feb-26-24	Initiated	Leerink Partners	Outperform	$261
Jan-03-24	Initiated	Barclays	Overweight	$242
Dec-14-23	Initiated	Wells Fargo	Equal Weight	$213
Mar-31-23	Initiated	Citigroup	Buy	$185
Jan-31-23	Resumed	Evercore ISI	Outperform	$185
Oct-11-22	Upgrade	BofA Securities	Neutral → Buy	$160 → $169
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight
Jul-11-22	Downgrade	Evercore ISI	Outperform → In-line	$150
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy	$167 → $178
May-26-22	Upgrade	Barclays	Equal Weight → Overweight
Apr-12-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$178
Apr-01-22	Resumed	Credit Suisse	Outperform	$180
Feb-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-21	Upgrade	BofA Securities	Underperform → Neutral
Jun-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$112
Apr-23-20	Resumed	Credit Suisse	Outperform	$105
Apr-01-20	Upgrade	JP Morgan	Neutral → Overweight	$93 → $106

Show Previous Ratings

Aug-15-25 09:40AM	Why Cencora (COR) is a Top Value Stock for the Long-Term (Zacks)
Aug-13-25 11:34PM	Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest (StockStory)
09:44AM	Cencora Stock: Analyst Estimates & Ratings (Barchart)
01:34AM	The 5 Most Interesting Analyst Questions From Cencora's Q2 Earnings Call (StockStory)
Aug-12-25 05:14PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
03:16AM	Loading…
03:16AM	COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update (StockStory)
Aug-11-25 12:45PM	3 Reasons Growth Investors Will Love Cencora (COR) (Zacks)
Aug-08-25 09:39AM	Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings? (Zacks)
Aug-07-25 07:44PM	Analyst Report: Cardinal Health, Inc. (Morningstar Research)
11:00AM	ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up (Zacks)
08:18AM	STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View (Zacks)
Aug-06-25 09:02PM	Analyst Report: McKesson Corporation (Morningstar Research)
07:36PM	Analyst Report: Cencora, Inc. (Morningstar Research)
05:26PM	Mckesson lifts annual profit forecast on robust demand for specialty drugs (Reuters)
01:13PM	Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook (Benzinga)
10:28AM	Loading…
10:28AM	COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised (Zacks)
09:30AM	Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:24AM	CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View (Zacks)
07:40AM	Cencora (COR) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:48AM	Cencora's (NYSE:COR) Q2 Sales Top Estimates (StockStory)
06:44AM	Cencora: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Cencora Reports Fiscal 2025 Third Quarter Results (Business Wire)
Aug-05-25 09:05AM	Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top (Zacks)
Aug-04-25 11:11PM	What To Expect From Cencora's (COR) Q2 Earnings (StockStory)
12:08PM	Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results? (Zacks)
08:35AM	DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock? (Zacks)
08:30AM	Zimmer Biomet to Report Q2 Earnings: Here's What to Expect (Zacks)
08:00AM	Mallinckrodt Names Leslie Donato to Board of Directors (PR Newswire)
Aug-01-25 09:15AM	Gear Up for Cencora (COR) Q3 Earnings: Wall Street Estimates for Key Metrics (Zacks)
08:50AM	Will Healthcare Growth Help STE Beat on Q1 Earnings? (Zacks)
08:50AM	Loading…
08:50AM	SYK Stock Falls Despite Q2 Earnings & Sales Beat, '25 View Up (Zacks)
Jul-31-25 11:40AM	BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down (Zacks)
10:01AM	CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised (Zacks)
10:00AM	Progyny (PGNY) Earnings Expected to Grow: Should You Buy? (Zacks)
08:48AM	DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise (Zacks)
08:46AM	ALGN Stock Falls on Q2 Earnings and Revenue Miss, Margins Down (Zacks)
Jul-30-25 10:00AM	Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:20AM	Charles River Q2 Earnings Preview: What's in Store for the Stock? (Zacks)
05:13AM	Elevance names former Cencora CEO to board (Healthcare Dive)
Jul-29-25 06:05PM	Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:49AM	WGS Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 Sales View (Zacks)
09:40AM	Are Medical Stocks Lagging McKesson (MCK) This Year? (Zacks)
08:54AM	Will SYK's Q2 Earnings Reflect Strong Growth Despite Tariff Overhang? (Zacks)
08:07AM	Henry Schein to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-28-25 12:41PM	Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter? (Zacks)
12:38PM	Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings? (Zacks)
10:11AM	RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View (Zacks)
09:26AM	Will Exome and Genome Growth Boost WGS' Q2 Earnings? (Zacks)
07:56AM	IDEXX to Release Q2 Earnings: What's in Store for the Stock? (Zacks)
06:57AM	Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel (GlobeNewswire)
Jul-25-25 12:23PM	Integer Holdings Q2 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
08:42AM	EW Stock Climbs on Q2 Earnings & Revenue Beat, Margins Down (Zacks)
Jul-24-25 11:11AM	Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat? (Zacks)
10:46AM	WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit (Zacks)
10:25AM	Cencora, Inc. (COR): A Bull Case Theory (Insider Monkey)
10:15AM	Will DXCM Q2 Earnings Reflect U.S. Coverage Expansion & Stelo Impact? (Zacks)
10:08AM	Can Robust Invisalign Momentum Drive Align Technology's Q2 Earnings? (Zacks)
Jul-23-25 11:59AM	Boston Scientific Beats on Q2 Earnings, Raises 2025 View, Stock Up (Zacks)
10:01AM	Universal Health to Report Q2 Earnings: What Do the Key Estimates Say? (Zacks)
08:35AM	ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts (Zacks)
Jul-22-25 12:11PM	WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up? (Zacks)
10:01AM	Farmina Pet Foods Expands U.S. Veterinary Presence with National Distribution Agreement with MWI Animal Health (PR Newswire)
08:39AM	Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises (Zacks)
07:43AM	Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings (Zacks)
Jul-21-25 10:35AM	HCA Healthcare to Report Q2 Earnings: Key Estimates to Note (Zacks)
08:38AM	ECL Unveils ReadyDose Cleaning Program for Southeast Asian Restaurants (Zacks)
08:30AM	Labcorp Q2 Earnings Preview: Diagnostics Strength in Focus (Zacks)
08:05AM	DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance? (Zacks)
Jul-18-25 12:03PM	Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings (Zacks)
12:00PM	Good Neighbor Pharmacy Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2025 (Business Wire)
11:26AM	Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock? (Zacks)
10:26AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
08:35AM	TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus (Zacks)
08:27AM	Should You Add Edwards Lifesciences Stock to Your Portfolio Now? (Zacks)
Jul-17-25 11:33AM	ISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA Approval (Zacks)
Jul-16-25 12:35PM	ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines (Zacks)
12:26PM	Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now (Zacks)
09:42AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
09:04AM	GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain? (Zacks)
08:38AM	Should You Continue to Hold Veracyte Stock in Your Portfolio Now? (Zacks)
08:19AM	Is it Prudent to Retain Charles River Stock in Your Portfolio Now? (Zacks)
06:20AM	Should Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) Be on Your Investing Radar? (Zacks)
Jul-15-25 01:37PM	Sightview Expands Leadership Bench, Appointing Vice Presidents of Client Operations and Product Management (Business Wire)
09:12AM	BD Partners With Waters to Build High-Volume Diagnostics Leader (Zacks)
09:02AM	Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings? (Zacks)
Jul-14-25 08:29AM	ABT to Report Q2 Earnings: CGM and Cardiac Devices in Focus (Zacks)
08:07AM	Bio-Rad Stock Climbs Following the Launch of Four ddPCR Platforms (Zacks)
Jul-12-25 02:40PM	Cencora, Inc. (COR): If It Was Down, I'd Say "Double Down And Buy," Says Jim Cramer (Insider Monkey)
Jul-11-25 12:10PM	Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:57AM	InspireMD Launches CGuard Prime Carotid Stent System in the U.S. (Zacks)
08:02AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
Jul-10-25 12:09PM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
08:21AM	ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise? (Zacks)
08:19AM	Should You Continue to Hold STERIS Stock in Your Portfolio Now? (Zacks)
08:19AM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
08:18AM	Is it Worth Adding Boston Scientific Stock to Your Portfolio Now? (Zacks)
Jul-09-25 12:04PM	AMN Stock Gains Post Latest Deals With symplr to Boost Operations (Zacks)
11:57AM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
08:29AM	Alcon Stock Gains Following UNITY VCS' Approval in Canada (Zacks)
08:21AM	Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now? (Zacks)

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Option Exercise	86.09	12,578	1,082,840	324,491	Jul 23 04:30 PM
COLLIS STEVEN H	Executive Chairman	Jul 22 '25	Sale	292.67	14,578	4,266,543	309,913	Jul 23 04:30 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Option Exercise	86.09	3,225	277,640	47,319	Jul 22 04:23 PM
Mauch Robert P.	President & CEO	Jul 18 '25	Sale	294.11	4,968	1,461,138	42,351	Jul 22 04:23 PM
COLLIS STEVEN H	Director	Jul 22 '25	Proposed Sale	292.67	14,578	4,266,543		Jul 22 09:47 AM
Mauch Robert P.	Officer	Jul 18 '25	Proposed Sale	294.11	4,968	1,461,138		Jul 18 11:44 AM
COLLIS STEVEN H	Executive Chairman	Jun 24 '25	Option Exercise	86.09	12,579	1,082,926	326,492	Jun 25 04:03 PM
COLLIS STEVEN H	Executive Chairman	Jun 24 '25	Sale	292.62	14,579	4,266,107	311,913	Jun 25 04:03 PM
COLLIS STEVEN H	Director	Jun 24 '25	Proposed Sale	292.62	14,579	4,266,107		Jun 24 10:21 AM
Battaglia Silvana	Executive Vice President	Jun 18 '25	Sale	297.40	4,077	1,212,520	11,297	Jun 20 04:06 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Option Exercise	86.09	3,225	277,640	49,063	Jun 20 04:04 PM
Mauch Robert P.	President & CEO	Jun 18 '25	Sale	295.30	4,969	1,467,346	44,094	Jun 20 04:04 PM
Lon Greenberg	Board of directors	Jun 18 '25	Proposed Sale	293.20	1,000	293,200		Jun 18 04:40 PM
Battaglia Silvana	Officer	Jun 18 '25	Proposed Sale	297.41	4,077	1,212,520		Jun 18 12:58 PM
Mauch Robert P.	Officer	Jun 18 '25	Proposed Sale	295.30	4,969	1,467,346		Jun 18 09:50 AM
Krikorian Lazarus	SVP & Chief Accounting Officer	May 29 '25	Sale	288.96	3,000	866,881	17,154	Jun 02 04:08 PM
Krikorian Lazarus	Officer	May 29 '25	Proposed Sale	288.96	3,000	866,881		May 29 11:37 AM
Mauch Robert P.	President & CEO	May 19 '25	Option Exercise	86.09	3,225	277,640	50,807	May 21 04:04 PM
Mauch Robert P.	President & CEO	May 19 '25	Sale	291.43	4,969	1,448,116	45,838	May 21 04:04 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Option Exercise	86.09	12,578	1,082,840	328,491	May 21 04:00 PM
COLLIS STEVEN H	Executive Chairman	May 20 '25	Sale	293.84	14,578	4,283,600	313,913	May 21 04:00 PM
COLLIS STEVEN H	Director	May 20 '25	Proposed Sale	293.84	14,578	4,283,600		May 20 09:45 AM
Hopfield Jessica	Member of immediate family of	May 19 '25	Proposed Sale	293.24	12,185	3,573,163		May 19 02:29 PM
Mauch Robert P.	Officer	May 19 '25	Proposed Sale	291.43	4,969	1,448,116		May 19 09:51 AM
GREENBERG LON R	Director	May 14 '25	Sale	279.05	3,000	837,150	17,851	May 16 04:23 PM
GREENBERG LON R	Director	May 14 '25	Proposed Sale	279.05	3,000	837,150		May 14 03:53 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Option Exercise	86.09	12,579	1,082,926	330,492	Apr 23 04:24 PM
COLLIS STEVEN H	Executive Chairman	Apr 22 '25	Sale	281.81	14,579	4,108,508	315,913	Apr 23 04:24 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Option Exercise	86.09	3,225	277,640	52,551	Apr 22 04:06 PM
Mauch Robert P.	President & CEO	Apr 21 '25	Sale	289.33	4,969	1,437,681	47,582	Apr 22 04:06 PM
COLLIS STEVEN H	Director	Apr 22 '25	Proposed Sale	281.81	14,579	4,108,508		Apr 22 09:42 AM
Mauch Robert P.	Officer	Apr 21 '25	Proposed Sale	289.33	4,969	1,437,681		Apr 21 09:48 AM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Option Exercise	86.09	12,578	1,082,840	332,491	Mar 26 04:40 PM
COLLIS STEVEN H	Executive Chairman	Mar 25 '25	Sale	269.51	14,578	3,928,917	317,913	Mar 26 04:40 PM
Campbell Elizabeth S	Executive Vice President	Mar 24 '25	Sale	268.28	4,127	1,107,192	14,665	Mar 26 04:38 PM
COLLIS STEVEN H	Director	Mar 25 '25	Proposed Sale	269.51	14,578	3,928,917		Mar 25 10:16 AM
Campbell Elizabeth S	Officer	Mar 24 '25	Proposed Sale	268.28	4,127	1,107,192		Mar 24 10:53 AM
Mauch Robert P.	President & CEO	Mar 18 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 19 04:38 PM
Mauch Robert P.	President & CEO	Mar 18 '25	Sale	260.93	4,970	1,296,822	49,326	Mar 19 04:38 PM
Mauch Robert P.	Officer	Mar 18 '25	Proposed Sale	260.93	4,970	1,296,822		Mar 18 12:05 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Mar 10 '25	Sale	260.06	2,000	520,120	20,154	Mar 11 04:07 PM
Krikorian Lazarus	Officer	Mar 10 '25	Proposed Sale	260.06	2,000	520,120		Mar 10 02:09 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Option Exercise	86.09	3,226	277,726	54,296	Mar 04 05:35 PM
Mauch Robert P.	President & CEO	Mar 03 '25	Sale	255.00	4,970	1,267,350	51,070	Mar 04 05:35 PM
Mauch Robert P.	Officer	Mar 03 '25	Proposed Sale	255.00	4,970	1,267,350		Mar 03 03:28 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Option Exercise	86.09	12,579	1,082,926	332,492	Feb 28 04:05 PM
COLLIS STEVEN H	Executive Chairman	Feb 27 '25	Sale	251.08	14,579	3,660,495	319,913	Feb 28 04:05 PM
COLLIS STEVEN H	Director	Feb 27 '25	Proposed Sale	251.08	14,579	3,660,495		Feb 27 11:26 AM
Battaglia Silvana	Executive Vice President	Feb 21 '25	Sale	242.24	5,000	1,211,200	15,374	Feb 24 05:25 PM
Battaglia Silvana	Officer	Feb 21 '25	Proposed Sale	242.24	5,000	1,211,200		Feb 21 12:18 PM
Walgreens Boots Alliance, Inc.	10% Owner	Feb 06 '25	Sale	244.51	1,286,376	314,531,796	12,570,000	Feb 10 07:35 PM
Walgreens Boots Alliance Holdi	Affiliate	Feb 06 '25	Proposed Sale	246.13	1,081,885	266,284,355		Feb 06 07:55 PM
Battaglia Silvana	Executive Vice President	Dec 20 '24	Sale	228.72	1,678	383,792	20,329	Dec 23 03:47 PM
Battaglia Silvana	Officer	Dec 20 '24	Proposed Sale	228.72	1,678	383,792		Dec 20 01:48 PM
Krikorian Lazarus	SVP & Chief Accounting Officer	Dec 03 '24	Sale	250.41	1,816	454,754	21,988	Dec 04 04:22 PM
Krikorian Lazarus	Officer	Dec 03 '24	Proposed Sale	250.42	1,816	454,754		Dec 03 11:13 AM
Cleary James F	Chief Financial Officer	Nov 27 '24	Option Exercise	89.58	33,877	3,034,702	171,508	Dec 02 04:01 PM
COLLIS STEVEN H	Executive Chairman	Nov 25 '24	Sale	243.97	50,000	12,198,750	326,557	Nov 26 04:31 PM
COLLIS STEVEN H	Director	Nov 25 '24	Proposed Sale	243.98	50,000	12,198,760		Nov 25 04:04 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Option Exercise	89.58	21,509	1,926,776	328,261	Nov 21 04:49 PM
COLLIS STEVEN H	Executive Chairman	Nov 19 '24	Sale	242.16	21,509	5,208,619	306,752	Nov 21 04:49 PM
COLLIS STEVEN H	Director	Nov 19 '24	Proposed Sale	242.16	21,509	5,208,619		Nov 19 10:00 AM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Oct 23 04:06 PM
COLLIS STEVEN H	Executive Chairman	Oct 22 '24	Sale	235.80	21,509	5,071,822	285,088	Oct 23 04:06 PM
COLLIS STEVEN H	Officer	Oct 22 '24	Proposed Sale	235.80	21,509	5,071,822		Oct 22 10:43 AM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Option Exercise	89.58	21,509	1,926,776	306,597	Sep 18 04:37 PM
COLLIS STEVEN H	Chairman, President & CEO	Sep 17 '24	Sale	241.01	21,509	5,183,884	285,088	Sep 18 04:37 PM
Lon Greenberg	Other: Board	Sep 17 '24	Proposed Sale	239.88	4,000	959,520		Sep 17 05:27 PM
COLLIS STEVEN H	Officer	Sep 17 '24	Proposed Sale	241.01	21,509	5,183,884		Sep 17 09:36 AM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Option Exercise	89.58	10,754	963,343	295,842	Aug 21 04:08 PM
COLLIS STEVEN H	Chairman, President & CEO	Aug 20 '24	Sale	239.13	10,754	2,571,604	285,088	Aug 21 04:08 PM
COLLIS STEVEN H	Officer	Aug 20 '24	Proposed Sale	239.13	10,754	2,571,604		Aug 20 10:47 AM

BTSG

BrightSpring Health Services Inc

COR

Cencora Inc

Upgrade your FINVIZ experience